Notably, sustained ATRA/GM-CSF treatment of mature HT93 cells led to elimination of the major leukemia-derived neutrophil population, resulting in exclusive persistence of human AML-derived eosinophil-like cells (Fig. 8a and Supplementary Fig. 9a). Here, CSF2 is linked to leukemia.